Form 4: Sabra Health Care REIT CEO Richard Matros Acquires Shares Through Vesting of Performance-Based Stock Units
SEC Form 4 Filing
Richard Matros, CEO of Sabra Health Care REIT, acquired 285,144 shares of common stock through the vesting of performance-based stock units.
Summary
- Richard Matros, the CEO of Sabra Health Care REIT, acquired 285,144 shares of common stock on January 15, 2025.
- These shares were acquired through the vesting of stock units granted under the company's 2009 Performance Incentive Plan.
- The vesting was based on a relative total stockholder return (TSR) award granted on December 28, 2021.
- The Compensation Committee determined that the TSR units earned were 200% of the target, based on the company's performance compared to a group of peer companies over a three-year period.
- Additionally, Mr. Matros holds 1,624,750 shares indirectly through the R&A Matros Revocable Trust.
- The vested units will be paid in shares of common stock on or about January 2, 2026, subject to earlier payment in certain circumstances.
Sentiment
Score: 8
Explanation: The document indicates strong performance leading to the vesting of stock units at 200% of the target, which is a positive signal. The CEO's increased shareholding also suggests confidence in the company's future.
Positives
- The vesting of performance-based stock units indicates that the company met its performance targets.
- The 200% achievement of the target for total stockholder return (TSR) suggests strong performance relative to peer companies.
- The acquisition of shares by the CEO can be seen as a positive sign of confidence in the company's future.
Future Outlook
The vested stock units will be paid in shares of common stock on or about January 2, 2026, subject to earlier payment in the event of death, disability or change of control.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. The vesting of performance-based stock units is a typical form of executive compensation, aligning management's interests with those of shareholders.
Comparison to Industry Standards
- The use of performance-based stock units is a common practice among publicly traded companies, particularly in the REIT sector, to incentivize executives.
- The three-year performance period is also a standard timeframe for such awards.
- The 200% achievement of the target suggests that Sabra's performance was strong compared to its peers, which is a positive indicator for investors.
Stakeholder Impact
- The vesting of performance-based stock units and the CEO's increased shareholding could positively impact shareholder confidence.
- The strong performance indicated by the 200% target achievement could also be viewed positively by other stakeholders.
Next Steps
- The vested stock units will be paid in shares of common stock on or about January 2, 2026.
Key Dates
| Date | Description |
|---|---|
| 12/28/2021 | Date of grant for the relative total stockholder return-based stock unit (TSR units) award. |
| 01/15/2025 | Date of the transaction where the stock units vested and the Compensation Committee determined the 200% target achievement. |
| 01/17/2025 | Date of the signature of the form. |
| 01/02/2026 | Estimated date for the payment of the vested stock units in shares of common stock. |
Keywords
Sabra Health Care REIT, Richard Matros, stock units, vesting, performance incentive plan, total stockholder return, TSR, executive compensation, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.